On Monday, Halcón Resources Corporation (NYSE:HK)’s shares gained 16.35%, and closed at $1.85, after Halcón Resources Corporation, declared plans to release itsfirst quarter 2015 financial results on Tuesday, May 5, 2015 after trading closes on the New York Stock Exchange.
The Corporation has also planned a conference call to talk about the release for Wednesday, May 6, 2015 at 10:00 a.m. EDT(9:00 a.m. CDT). Investors may take part in the conference call via telephone by dialing (877) 810-3368 for domestic callersor (914) 495-8561 for international callers, in both cases using conference ID 20710637, and asking for the Halcon call a few minutes preceding to the start time.
Halcón Resources Corporation, an independent energy corporation, is engaged in the attainment, production, exploration, and development of onshore oil and natural gas properties in the United States.
Cytori Therapeutics, Inc. (NASDAQ:CYTX)’s shares jumped 13.79%, and settled at $1.32, during the last trading session on Monday, as Cytori Therapeutics, Inc., declared that its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution® System by the State Food and Drug Administration of the People’s Republic of China (CFDA). This regulatory clearance officially makes Cytori’s Celution System accessible in the largest healthcare market in the world and triggers a substantial 2015 product purchase order for Cytori from Lorem Vascular.
Cytori’s exclusive licensee in the region, Lorem Vascular, has worked closely with Cytori during the last year preparing for CFDA clearance and planning for commercial introduction of the Celution family of products in China. Recent news marks the first time that Cytori’s Celution System has gained any level of access to the mainland Chinese healthcare market. Lorem Vascular will start product launch of Celution in key hospitals in China right away.
In November 2013, Cytori Therapeutics and Lorem Vascular reached a 30-year exclusive licensing contract to commercialize Cytori Celution System in China, Hong Kong, Malaysia, Singapore, and Australia. As part of that contract, Lorem Vascular agreed to pay up to $500 million in fees to Cytori for a 30-year exclusive license for all indications, not including alopecia, in the licensed territories following specific proceed milestones, in addition to royalties of 30% on gross profits from Lorem’s operations in China, Malaysia and Hong Kong. Furthermore, following recent news, Lorem Vascular placed an opening order of 23 Celution Devices and 1,100 Celution Consumable Sets, which is anticipated to be fulfilled throughout 2015. Following this opening order, Lorem Vascular has agreed to purchase annually a minimum of fifty (50) Celution Devices and fifty (50) Celution Consumable Sets for each of the Celution Devices for the next three years from CFDA clearance.
Cytori Therapeutics is a late stage cell therapy corporation developing laboratory equipment and autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair.
At the end of Monday’s trade, Rex Energy Corporation (NASDAQ:REXX)’s shares climbed 13.77%, and closed at $4.38, as on March 31, Rex Energy Corporation, declared a new joint venture contract in the Butler Operated Area, re-determined borrowing base and amended financial covenants to the senior secured credit facility.
Joint Venture Contract:
Rex Energy has reached a joint venture contract with an associate of ArcLight Capital Partners, LLC to jointly develop 32 specifically designated wells in the corporation’s Butler Operated Area. ArcLight will take part and fund 35% of the well costs in the designated wells. The joint venture contract is predictable to reduce the corporation’s 2015 capital expenditure program by $60 million to $135 - $145 million, or a decrease of 30% at the midpoint of guidance. Total consideration for the transaction will equal $67 million, with $16.6 million received at closing. Upon achieving certain threshold triggers of IRR and ROI on specific well groups, ArcLight’s working interest will revert to 17.5%. In addition, ArcLight will have the option to take part as a 20% working interest partner in 17 additional Moraine East wells in 2016.
“This joint venture is consistent with our 2015 strategy to further HBP our liquids-rich prospects in the Butler Operated Area, specifically in the Moraine East Area,” said Tom Stabley, Rex Energy’s Chief Executive Officer. “This new relationship provides greater flexibility for Rex to manage its capital program, while ongoing to raise production and reserves. We continue to evaluate solutions that will further enhance our ability to develop the Butler Operated Area.”
Rex Energy Corporation operates as an independent oil, natural gas liquid, and natural gas corporation in the Appalachian and Illinois basins in the United States. The corporation focuses on the Marcellus Shale, Utica Shale, and Burkett Shale drilling and exploration activities in the Appalachian Basin, in addition to on developmental oil drilling and the implementation of improved oil recovery on its properties in the Illinois Basins.
Coeur Mining, Inc. (NYSE:CDE), ended its Monday’s trading session with 11.04% gain, and closed at $5.23, after Coeur Mining, reported preliminary first quarter production of 3.8 million ounces of silver and 69,734 ounces of gold, or 8.0 million silver equivalent ounces.
Coeur will report its full operational and financial results for the first quarter 2015 on May 4, 2015 after the New York Stock Exchange closes for trading. There will be a conference call on May 5, 2015 at 11:00 a.m. Eastern time.
Hosting the call will be Mitchell J. Krebs, President and Chief Executive Officer of Coeur, who will be joined by Peter C. Mitchell, Senior Vice President and Chief Financial Officer, Frank L. Hanagarne, Jr., Senior Vice President and Chief Operating Officer, Hans Rasmussen, Vice President of Exploration, Joe Phillips, Senior Vice President and Chief Development Officer, and other members of administration.
Coeur Mining is the largest U.S.-based primary silver producer and a noteworthy gold producer with five precious metals mines in the Americas employing about 2,100 people. Coeur produces from its wholly owned operations: the Palmarejo silver-gold mine in Mexico, the San Bartolome silver mine in Bolivia, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska, and the Wharf gold mine in South Dakota.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
